rituximab
roche,biogen
[]
vikse et al. norwegian case series of 40 patients treated with rtx for igg4-rd. efficacy across phenotypes 80-100% for improvement but only 45-78% for remission. #acr22 abstr#0147 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC